Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary

Condition:   Carcinoma of Unknown PrimaryInterventions:   Drug: carboplatin;   Drug: everolimus;   Drug: paclitaxel;   Genetic: gene expression analysis;   Other: laboratory biomarker analysisSponsors:   National Cancer Institute (NCI);   North Central Cancer Treatment Group;   National Cancer Institute (NCI)Recruiting - verified December 2012

Source: ClinicalTrials.gov - July 8, 2009 Category: Research Source Type: clinical trials